Health

FDA questions consumer use of antimicrobial soap

The move comes in the wake of increasing concerns that bacteria are becoming resistant to a growing number of antibiotics.

By Victoria Stagg Elliott — Posted Nov. 14, 2005

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

Soaps and lotions that include antibacterial agents have no benefit over ordinary soap and water, but more research is needed to allay or substantiate concern that these substances may be leading to increased rates of antibiotic resistance. This is the conclusion of the Food and Drug Administration's Nonprescription Drugs Advisory Committee, which met last month to consider the use of these products outside of the health care setting.

"In the absence of proven benefit, there's no real reason to encourage the use of these products," said Alastair J.J. Wood, MD, committee chair and associate dean at Tennessee's Vanderbilt Medical School.

The agency is not bound by its committee's recommendations but usually follows them.

The finding was praised by physicians who have long expressed concerns that the use of antibacterial soaps and lotions by consumers may be doing more harm than good. For example, the American Medical Association's Council on Scientific Affairs published a report in the August 2002 Archives of Dermatology that it was prudent to avoid these products since evidence on their efficacy was lacking and the issue of antibiotic resistance is so critical.

"We urge the FDA to evaluate the safety and effectiveness of antimicrobials in consumer products and strongly urge FDA regulation of them where resistance against antimicrobials has been demonstrated," said AMA Trustee Ronald M. Davis, MD.

Manufacturers countered that these products were a valuable option for consumers.

"Antibacterial products are proven to control the risks associated with exposure to potentially pathogenic organisms, providing consumers with a valuable extra measure of protection," read a joint statement issued after the meeting by the Soap and Detergent Assn. and the Cosmetic, Toiletry and Fragrance Assn.

Committee members argued, however, that evidence that these products kill various infectious agents was not sufficient to conclude that they also reduce illness. The question of the contribution these products may make to resistance also needs to be answered.

"What matters is whether they reduce the incidence of infection," said Dr. Wood.

Back to top


External links

Briefing documents for the Oct. 20 meeting of the Food and Drug Administration's Nonprescription Drugs Advisory Committee (link)

"Use of Antimicrobial Agents in Consumer Products," abstract, Archives of Dermatology, August 2002 (link)

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story